FREMOX-CV 625 Tablets for Bacterial Infections Fresaw Pharma

Fresaw-Pharma-FREMOX-CV625-Amoxycillin-Clavulanic-Acid-Tablets

Product Description

FREMOX-CV 625 Tablets are a broad-spectrum antibacterial combination of Amoxycillin, a β-lactam antibiotic, and Clavulanic Acid, a β-lactamase inhibitor.

This potent duo offers enhanced protection against resistant bacterial infections by preventing bacterial enzymes from destroying Amoxycillin.

It provides powerful infection control, quick symptom relief, and dependable recovery in both upper and lower respiratory infections, urinary tract infections, skin infections, and more.

Composition

Therapeutic Indications

FREMOX-CV 625 is indicated for the treatment of:

Respiratory tract infections (bronchitis, sinusitis, pneumonia)

Otitis media and tonsillitis

Urinary tract infections (UTI)

Skin and soft tissue infections

Dental infections and abscesses

Bone and joint infections

Mechanism of Action

Amoxycillin: Inhibits bacterial cell wall synthesis, leading to bacterial death.

Clavulanic Acid: Inhibits β-lactamase enzymes that inactivate Amoxycillin, restoring its antibacterial efficacy.

Dosage & Administration

Recommended Dose: One tablet twice daily or as directed by the physician.

Route: Oral

Storage: Store below 25°C in a cool, dry place. Protect from moisture.

Packaging

10 × 10 Tablets (Alu-Alu Pack)

Precautions

Use under medical supervision only.

Not recommended in patients allergic to penicillins.

May cause mild gastrointestinal disturbances.

Maintain adequate hydration during treatment.

Disclaimer

This information is intended for medical and educational reference only. Please consult a qualified healthcare professional before use.